CASE REPORTS
JOURNAL ARTICLE
Therapeutic efficacy of intravitreal bevacizumab on posterior uveitis complicated by neovascularization.
Acta Ophthalmologica 2009 May
PURPOSE: To evaluate the therapeutic effect of intravitreal bevacizumab in patients with uveitis-associated choroidal/retinal neovascularization.
METHODS: Two female patients (40 years, 15 years) with posterior uveitis, (one presumed ocular sarcoidosis, one lupus) were evaluated for neovascularization of the posterior segment. Both patients were given a single dose of 1.25 mg intravitreal bevacizumab.
RESULTS: Significant anatomical and functional recovery was evident in both patients within a few weeks.
CONCLUSION: In selected uveitic patients, bevacizumab may be an option for managing neovascularization.
METHODS: Two female patients (40 years, 15 years) with posterior uveitis, (one presumed ocular sarcoidosis, one lupus) were evaluated for neovascularization of the posterior segment. Both patients were given a single dose of 1.25 mg intravitreal bevacizumab.
RESULTS: Significant anatomical and functional recovery was evident in both patients within a few weeks.
CONCLUSION: In selected uveitic patients, bevacizumab may be an option for managing neovascularization.
Full text links
Trending Papers
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app